Effect of nicardipine versus enalapril on plasma endothelin-1 in hypertensive patients with type 2 diabetes mellitus

Clinical and Experimental Hypertension

Volumn 22, Issue 7-8, 2000, Pages 695-703

  Iwase, Masanori ^a   Doi, Yasufumi ^a   Goto, Daisuke ^a   Ichikawa, Kojiro ^a   Iino, Kenzo ^a   Yoshinari, Mototaka ^a   Fujishima, Masatoshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Enalapril; Endothelin 1; Microalbuminuria; Natriuresis; Nicardipine

Indexed keywords

BETA 2 MICROGLOBULIN; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ENDOTHELIN 1; NICARDIPINE;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; FEMALE; HUMAN; HYPERTENSION; MALE; NATRIURESIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; PROTEINURIA;

EID: 0033658531     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.1081/CEH-100102001     Document Type: Article

References (27)

1. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
2. Endothelins
3. Endothelins in normal and diseased kidney
4. Effect of a specific endothelin receptor A antagonist on mRNA levels for extracellular matrix components and growth factors in diabetic glomeruli
5. Unselective inhibition of endothelin receptors reduces renal dysfunction in experimental diabetes
6. Elevated plasma endothelin in patients with diabetes mellitus
7. In addition to von Willebrand factor and urinary albumin excretion, plasma endothelin is an indicator of endothelial dysfunction in diabetes mellitus
8. Increased plasma levels of immunoreactivity endothelin-1 and von Willebrand factor in type 2 diabetes patients
9. National high blood pressure education program working group report on hypertension in diabetes
10. Drug treatment of hypertension in patients with diabetes
11. Management of early diabetic nephropathy
12. The effect of angiotensin-convertingenzyme inhibition on diabetic nephropathy
13. Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria
14. Calcium antagonists and the diabetic hypertensive patient
15. Effect of antihypertensive therapy on the kidney in patients with diabetes. A metaregression analysis
16. Therapeutic efficacy of different antihypertensive drugs in human diabetic nephropathy. An updated meta-analysis
17. Presence of immunoreactive endothelin in human plasma
18. The two-period cross-over clinical trial
19. Circulating endothelin-1 levels in lean non-insulin-dependent diabetic patients. Influence of ACE inhibition
20. Regulation of cortical collecting duct function. Effect of endothelin
21. Effects of endothelin-1 on renal function in humans. Implications for physiology and pathophysiology
22. Increased renal endothelin formation is associated with sodium retention and increased free water clearance
23. Antihypertensive and renal effects of nicardipine
24. Contrasting effects of lisinopril and nifedipine on albuminuria and tubular transport functions in insulin dependent diabetes with nephropathy
25. Renal tubular effects of calcium antagonists
26. Effects of different classes of calcium antagonist on proteinuria in diabetic subjects
27. Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment